Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesc Bosch

Showing results (31-40 of 170) with videos related to

Pageof 17
Sort By:
Bone Marrow Transplantation|February 14, 2026
CAR T-cell therapy in patients with acute lymphoblastic leukemia: a systematic review and meta-analysisVictor Navarro, Gloria Iacoboni, Sergi Camarillas, et al.
Leukemia Research|February 1, 2014
Analysis of the IGHV region in Burkitt's lymphomas supports a germinal center origin and a role for superantigens in lymphomagenesisMaria Joao Baptista, Eva Calpe, Eva Fernandez, et al.
Journal of Comparative Effectiveness Research|January 19, 2019
Facing real-life with direct oral anticoagulants in patients with nonvalvular atrial fibrillation: outcomes from the first observational and prospective study in a Spanish populationMaría Cerdá, Juan J Cerezo-Manchado, Erik Johansson, et al.
The American Journal of Pathology|January 27, 2004
Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survivalAntonio Martinez, Beatriz Bellosillo, Francesc Bosch, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 19, 2023
Indirect Treatment Comparisons of Mosunetuzumab With Third- and Later-Line Treatments for Relapsed/Refractory Follicular LymphomaFrancesc Bosch, John Kuruvilla, Theodoros P Vassilakopoulos, et al.
Cancer Treatment Reviews|September 3, 2023
From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemiaPau Abrisqueta, Ferran Nadeu, Jan Bosch-Schips, et al.
Haematologica|December 1, 2022
Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with <i>MYD88</i> L265P mutationIvan Dlouhy, Marc Armengol, Clara Recasens-Zorzo, et al.
Clinical Case Reports|May 27, 2022
Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative managementOlga Benitez Hidalgo, M Fernanda Martinez Garcia, Agustin Bescos Cabestre, et al.
Scientific Reports|February 22, 2020
An electronic alert system increases screening for hepatitis B and C and improves management of patients with haematological disordersMar Riveiro-Barciela, Paula Gubern, Luisa Roade, et al.
Haematologica|May 13, 2021
Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with <i>MYD88</i> L265P mutationIvan Dlouhy, Marc Armengol, Clara Recasens-Zorzo, et al.
Pageof 17

Showing results (31-40 of 170) with videos related to

Sort By:
Pageof 17
Bone Marrow Transplantation|February 14, 2026
CAR T-cell therapy in patients with acute lymphoblastic leukemia: a systematic review and meta-analysisVictor Navarro, Gloria Iacoboni, Sergi Camarillas, et al.
Leukemia Research|February 1, 2014
Analysis of the IGHV region in Burkitt's lymphomas supports a germinal center origin and a role for superantigens in lymphomagenesisMaria Joao Baptista, Eva Calpe, Eva Fernandez, et al.
Journal of Comparative Effectiveness Research|January 19, 2019
Facing real-life with direct oral anticoagulants in patients with nonvalvular atrial fibrillation: outcomes from the first observational and prospective study in a Spanish populationMaría Cerdá, Juan J Cerezo-Manchado, Erik Johansson, et al.
The American Journal of Pathology|January 27, 2004
Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survivalAntonio Martinez, Beatriz Bellosillo, Francesc Bosch, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 19, 2023
Indirect Treatment Comparisons of Mosunetuzumab With Third- and Later-Line Treatments for Relapsed/Refractory Follicular LymphomaFrancesc Bosch, John Kuruvilla, Theodoros P Vassilakopoulos, et al.
Cancer Treatment Reviews|September 3, 2023
From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemiaPau Abrisqueta, Ferran Nadeu, Jan Bosch-Schips, et al.
Haematologica|December 1, 2022
Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with <i>MYD88</i> L265P mutationIvan Dlouhy, Marc Armengol, Clara Recasens-Zorzo, et al.
Clinical Case Reports|May 27, 2022
Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative managementOlga Benitez Hidalgo, M Fernanda Martinez Garcia, Agustin Bescos Cabestre, et al.
Scientific Reports|February 22, 2020
An electronic alert system increases screening for hepatitis B and C and improves management of patients with haematological disordersMar Riveiro-Barciela, Paula Gubern, Luisa Roade, et al.
Haematologica|May 13, 2021
Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with <i>MYD88</i> L265P mutationIvan Dlouhy, Marc Armengol, Clara Recasens-Zorzo, et al.
Pageof 17